End point of the follow-up | Vaccine | Control | ||||||
N | Person yrs | n | Rate* | N | Person yrs | n | Rate* | |
FCR registered CIN3+ diagnoses | ||||||||
Active | 2472 | 10 199 | – | – | 15 665 | 62 628 | – | – |
Intermittent | 2 466 | 1 232 | 1 | 81 | 15 634 | 7 815 | – | – |
Passive | 2 465 | 12 561 | 4 | 32 | 15 627 | 85 328 | 79 | 93 |
KI re-reviewed CIN3+ diagnoses | ||||||||
Intermittent | 2 466 | 1 232 | 1 | 81 | 15 634 | 7 815 | – | – |
Passive | 2 465 | 12 561 | 3 | 24 | 15 627 | 85 328 | 50 | 59 |
Active (0–4 years), Intermittent (4–4.5 years), Passive (4.5–10 years)
*incidence/100 000 women years